Omnia Mohammed Hashem: Clinical Trials

1 trial sponsored by Omnia Mohammed Hashem, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 suspended. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Suspended 1

Follow Omnia Mohammed Hashem: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Anemia Correction and Fibroblast Growth Factor 23 Levels in Chronic Kidney Disease , and Renal Transplant Patient
detailed echocardiography, serum fibroblast growth factor-23, flow mediated dilatation of forearm - Anemia of Chronic Kidney Disease, Endothelial Dysfunction
Not applicableSuspendedOmnia Mohammed Hashem802018-09-012018-06-27

Conditions studied

Hypertrophy, Left Ventricular (1)

Countries

Egypt (1)

Top investigators

Mohammed Ali Tohamy, professor (1)

Results publications

PMID 23505057, PMID 26394828, PMID 26437603, PMID 26439537, PMID 26787561